NKE
NIKE, Inc.
NKE has the edge over SCI overall, supported by stronger valuation and stronger modeled upside.
SCI
Service Corporation International
SCI has lower modeled downside risk, despite its lower overall score.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
SCI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Weak |
SCI's profitability and cash flow are currently healthy, and its revenue is stable, but its balance sheet is weak.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over SCI in the historical PE scenario, which offers more potential upside but is not a forecast.
SCI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $60.18 | -20% |
| Forward | 18x | $74.97 | — |
| Current | 19x | $74.97 | — |
| Fair | 20x | $80.86 | +7.9% |
| Expensive | 22x | $88.36 | +18% |
Historical ranges are pointers, not guarantees.
SCI's PE is in its fair range at 19x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
SCI Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Stable | |
| Stable | |
| Limited | |
| High |
Analysts expect SCI's earnings to grow, with its revenue and profitability holding steady.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
SCI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.22 | +4.8% |
| Q3 2026 | $4.03 | +9.2% |
| Q2 2026 | $3.83 | +4.4% |
| Q1 2026 | $3.79 | +4.7% |
| Q4 2025 | $3.80 | +7.6% |
| Q3 2025 | $3.69 | +7% |
| Q2 2025 | $3.67 | +6.7% |
| Q1 2025 | $3.62 | +3.7% |
| Q4 2024 | $3.53 | 0% |
SCI has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
SCI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.1B | +4.6% |
| Q2 2026 | $1.1B | +3.6% |
| Q1 2026 | $1.1B | +2.1% |
| Q4 2025 | $1.1B | +1.7% |
| Q3 2025 | $1.1B | +4.4% |
| Q2 2025 | $1.1B | +3% |
| Q1 2025 | $1.1B | +2.8% |
| Q4 2024 | $1.1B | +3.5% |
SCI has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 23% | +1.4 points |
| Q2 2026 | 21% | -0.1 points |
| Q1 2026 | 22% | -1.2 points |
| Q4 2025 | 25% | +0.8 points |
| Q3 2025 | 21% | +0.4 points |
| Q2 2025 | 21% | -0.3 points |
| Q1 2025 | 23% | +1.2 points |
| Q4 2024 | 24% | +1.1 points |
SCI has the edge over NKE on profitability, with a higher operating margin.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
SCI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $197.4M | +31% |
| Q2 2026 | $142.9M | +71% |
| Q1 2026 | $253.9M | +9% |
| Q4 2025 | $87.2M | -43% |
| Q3 2025 | $150.7M | -7.5% |
| Q2 2025 | $83.4M | -17% |
| Q1 2025 | $233M | +66% |
| Q4 2024 | $151.8M | -17% |
SCI has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
SCI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.8% | -1.1M shares |
| 1 year | -3% | -4.2M shares |
| 3 years | -9.9% | -15.1M shares |
| 5 years | -19% | -32.8M shares |
| Available history | -26% | -48.3M shares |
SCI has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $52.6M |
| Q2 2026 | $123.2M |
| Q1 2026 | $143.2M |
| Q4 2025 | $58.9M |
| Q3 2025 | $78.1M |
| Q2 2025 | $193.6M |
| Q1 2025 | $130.5M |
| Q4 2024 | $56.2M |
SCI spent $378M buying back its own shares over the past year, down 18% from the year before.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE has the edge over SCI on leverage, with a lower net debt burden relative to earnings.
SCI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.0x | High |
| Q2 2026 | 4.1x | High |
| Q1 2026 | 4.1x | High |
| Q4 2025 | 4.0x | High |
| Q3 2025 | 4.0x | Elevated |
| Q2 2025 | 4.0x | High |
| Q1 2025 | 3.9x | Elevated |
| Q4 2024 | 4.0x | Elevated |
SCI's net debt is about 4.0 years of its operating earnings (EBITDA), about the same as a year ago.
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
SCI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.2 | Neutral |
| Stochastic | 31.6 | Neutral |
SCI's weekly RSI is 43 (neutral) and its Stochastic is 32 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over SCI on valuation relative to its sector.
SCI PE vs Consumer Cyclical Sector
| Metric | SCI | Sector median | Relative |
|---|---|---|---|
| PE | 19x | 18x | 3.2% above |
| PE % | 34 | 47 | 13 pts below |
SCI is trading at 19x earnings, in line with the Consumer Cyclical sector's median of 18x.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
SCI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $77.7 | 3.5% below |
| 20 week MA | $80.2 | 6.5% below |
| 50 week MA | $79.7 | 5.9% below |
| 100 week MA | $79.5 | 5.7% below |
| 200 week MA | $74.6 | 0.5% above |
SCI has fallen below most of its moving averages, though it's still 0.5% above its 200-week average.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
SCI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $46.1 | $48.7 | +5.6% |
| 2021 | $48.7 | $69.7 | +43% |
| 2022 | $69.7 | $70.2 | +0.8% |
| 2023 | $70.2 | $68.5 | -2.5% |
| 2024 | $68.5 | $80.8 | +18% |
| 2025 | $80.8 | $78.0 | -3.5% |
| 2026 YTD | $78.0 | $75.0 | -3.8% |
SCI has the edge over NKE on returns for 2026, with the stronger performance.